Ranitidine (oral)

Revision as of 20:43, 4 December 2014 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

{{DrugProjectFormSinglePage |authorTag=Ammu Susheela, M.D. [1] |genericName=Ranitidine |aOrAn=a |drugClass=antacid |indicationType=treatment |indication=relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages |adverseReactions=headache, constipation, diarrhoea, abdominal pain |blackBoxWarningTitle=Title |blackBoxWarningBody=ConditionName:

  • Content


|fdaLIADAdult=* Relieves heartburn associated with acid indigestion and sour stomach

  • Prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages
  • Ranitidine 150 mg (as ranitidine hydrochloride 168 mg)

|offLabelAdultGuideSupport======Condition1=====

  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Ranitidine (oral) in adult patients.

|offLabelAdultNoGuideSupport======Condition1=====

  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Ranitidine (oral) in adult patients.


|fdaLIADPed======Condition1=====

  • Dosing Information
  • Dosage
Condition2

There is limited information regarding FDA-Labeled Use of Ranitidine (oral) in pediatric patients.


|offLabelPedGuideSupport======Condition1=====

  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Ranitidine (oral) in pediatric patients.

|offLabelPedNoGuideSupport======Condition1=====

  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Ranitidine (oral) in pediatric patients.

|contraindications=* Condition1

|warnings======Allergy alert=====

  • Do not use if you are allergic to ranitidine or other acid reducers
  • Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor
  • Ask a doctor before use if you have
  • frequent chest pain
  • frequent wheezing, particularly with heartburn

unexplained weight loss

  • nausea or vomiting
  • stomach pain

had heartburn over 3 months. This may be a sign of a more serious condition.

  • heartburn with lightheadedness, sweating, or dizziness

chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

  • Stop use and ask a doctor if your heartburn continues or worsens

you need to take this product for more than 14 days

  • If pregnant or breast-feeding, ask a health professional before use.
  • Keep out of reach of children.

|useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Ranitidine (oral) in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Ranitidine (oral) during labor and delivery. |useInNursing=There is no FDA guidance on the use of Ranitidine (oral) with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Ranitidine (oral) with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Ranitidine (oral) with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Ranitidine (oral) with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Ranitidine (oral) with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Ranitidine (oral) in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Ranitidine (oral) in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Ranitidine (oral) in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Ranitidine (oral) in patients who are immunocompromised.

|administration=* Oral

  • Intravenous

|monitoring=There is limited information regarding Monitoring of Ranitidine (oral) in the drug label.

  • Description

|IVCompat=There is limited information regarding IV Compatibility of Ranitidine (oral) in the drug label.

|drugBox={{Drugbox2 | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 458460406 | IUPAC_name = N-(2-[(5-[(dimethylamino)methyl]furan-2-yl)methylthio]ethyl)-N'-methyl-2-nitroethene-1,1-diamine; dimethyl [(5-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine | image = Ranitidine Structural Formulae.png | width = 200 | image2 = Ranitidine-A-3D-balls.png

| tradename = Zantac | Drugs.com = Monograph | MedlinePlus = a601106 | licence_US = Ranitidine | pregnancy_AU = B1 | pregnancy_US = B | legal_AU = S2 | legal_US = OTC/RX | legal_status = P/POM (UK) | routes_of_administration = Oral, IV

| bioavailability = 39 to 88% | protein_bound = 15% | metabolism = Hepatic | elimination_half-life = 2–3 hours | excretion = 30–70% Renal

| CASNo_Ref =  ☑Y | CAS_number_Ref =  ☑Y | CAS_number = 66357-35-5 | ATC_prefix = A02 | ATC_suffix = BA02 | ATC_supplemental =
A02BA07 (WHO) (ranitidine bismuth citrate) | PubChem = 657345 | IUPHAR_ligand = 1234 | DrugBank_Ref =  ☑Y

| DrugBank = DB00863

| ChemSpiderID_Ref =  ☑Y | ChemSpiderID = 571454 | UNII_Ref =  ☑Y | UNII = 884KT10YB7 | KEGG_Ref =  ☑Y | KEGG = D00422 | ChEBI_Ref =  ☒N | ChEBI = 8776 | ChEMBL_Ref =  ☒N | ChEMBL = 1790041

| C=13 | H=22 | N=4 | O=3 | S=1 | molecular_weight = 314.4 g/mol | smiles = [O-][N+](=O)\C=C(\NC)NCCSCc1oc(cc1)CN(C)C | InChI = 1/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9- | InChIKey = VMXUWOKSQNHOCA-LCYFTJDEBT | StdInChI_Ref =  ☒N | StdInChI = 1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3 | StdInChIKey_Ref =  ☒N | StdInChIKey = VMXUWOKSQNHOCA-UHFFFAOYSA-N }} |mechAction=*

|structure=*

File:Ranitidine (oral)01.png
This image is provided by the National Library of Medicine.

|PD=There is limited information regarding Pharmacodynamics of Ranitidine (oral) in the drug label.

|PK=There is limited information regarding Pharmacokinetics of Ranitidine (oral) in the drug label.

|nonClinToxic=There is limited information regarding Nonclinical Toxicology of Ranitidine (oral) in the drug label.

|clinicalStudies=There is limited information regarding Clinical Studies of Ranitidine (oral) in the drug label.

|howSupplied=*

|fdaPatientInfo=There is limited information regarding Patient Counseling Information of Ranitidine (oral) in the drug label.

|alcohol=* Alcohol-Ranitidine (oral) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

|brandNames=* ®[1]

|lookAlike=* A® — B®[2]

|drugShortage= }} {{#subobject:

 |Label Page=Ranitidine (oral)
 |Label Name=Ranitidine (oral)11.png

}}

{{#subobject:

 |Label Page=Ranitidine (oral)
 |Label Name=Ranitidine (oral)11.png

}}

Synonyms / Brand Names: Ranitidine hydrochloride, Ranitidine HCL, Ranitidine Base, Rantidine HCL, Alquen, Alter-H2, Alvidina, Apo-Ranitidin, Artomil, Azuranit, Coralen, Digestosan, Ergan, Esofex, Fendibina, Gastrial, Gastridina, Gastrolav, Gastrosedol, Kuracid, Label, Lake, Logat, Melfax, Microtid, Mideran, Neugal, Noctone, Noktome, Normon, Novo-Radinine, Nu-Ranit, Pep-Rani, Ptinolin, Quadrin, Quantor, Radin, Ran H2, Ran Lich, Rani 2, Rani AbZ, Rani-BASF, Rani-Puren, Rani-Q, Rani-Sanorania, Rani-nerton, Raniben, Raniberl, Raniberta, Ranibloc, Ranic, Ranicux, Ranidil, Ranidin, Ranidine, Ranidura, Ranifur, Ranigasan, Ranigast, Ranigen, Ranilonga, Ranimerck, Raniogas, Raniplex, Ranisan, Ranitab, Ranitic, Ranitidin, Ranitidin 1A Pharma, Ranitidin AL, Ranitidin AWD, Ranitidin Arcana, Ranitidin Atid, Ranitidin Basics, Ranitidin Duncan, Ranitidin Dyna, Ranitidin Helvepharm, Ranitidin Heumann, Ranitidin Hexal, Ranitidin Merck, Ranitidin Millet, Ranitidin NM, Ranitidin Normon, Ranitidin PB, Ranitidin Stada, Ranitidin von ct, Ranitidin-Cophar, Ranitidin-Isis, Ranitidin-ratiopharm, Ranitidina Tamarang, Ranitidina predilu Grif, Ranitiget, Ranitin, Ranitine, Ranobel, Rantacid, Ranuber, Raticina, Regalil, Renatac, Rozon, Rubiulcer, Santanol, Serviradine, Sostril, Tanidina, Taural, Terposen, Toriol, Trigger, Ulcecur, Ulcex, Ulcirex, Ulcodin, Ulcolind Rani, Ulsaven, Ultidine, Viserul, Zandid, Zantac, Zantac 150, Zantac 75, Zantac In Plastic Container, Zantarac, Zantic

  1. Empty citation (help)
  2. "http://www.ismp.org". External link in |title= (help)